Drug intelligence / Profile preview

BM2216

Development stage: Phase 1
Lead developer: Nanjing Baimai Biotechnology
Modality: Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration: Oral

Overview

BM2216 is an extended-release small molecule drug under development for the treatment of diabetic neuropathies and other nervous system disorders. It was initially developed by Nanjing Baimai Biotechnology and is being further developed by Zhejiang Anglikang Pharmaceutical. The drug is currently in Phase 1 clinical trials. Its mechanism of action has not been explicitly detailed in public sources, but based on its comparison to melogabalin besilate in clinical studies and its therapeutic area, it is likely a gabapentinoid or related compound targeting neuropathic pain pathways[1][2][3][4][8].

Beyond the preview

Go deeper on BM2216.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BM2216.

Explore the full profile